Ascend Labs was started in the early 2000’s as a product development company. Ascend worked with multiple companies assisting them in developing off patent medicines that would be brought to market as generics. After spending several years in this support role Ascend acquired a sales and marketing business which then enabled Ascend to develop and obtain FDA approval in its own name and launch these products into the market under its own label. In 2008 Ascend entered the market with its first three products in its own label.

Ascend then adopted a bifurcated strategy. It continued with its own organic in house development projects which would lead to additional FDA approvals that could be marketed and also sought out quality partners that had the expertise to gain FDA approvals but who lacked the ability to do product promotion, distribution and sales.

Ascend is a wholly owned subsidiary of ThePharmaNetwork, LLC, which is a subsidiary of S & B Holdings S.a.r.l., which is a wholly owned subsidiary of Alkem. This provided Ascend with the global strength of Alkem’s world‑class R&D, advanced manufacturing capabilities, and international supply chain—combined with strong commercial expertise in the U.S. market.

Today, Ascend offer 300+ SKUs across hospitals, pharmacies, and wholesalers nationwide and continue to grow through innovation, strategic partnerships, and a commitment to improving patient access to essential medicines.